Delivery Order SPE2DR25D9331-SPE2DR26FQQH4
- Not listed
- The Defense Logistics Agency issued a $1,461.84 delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for Lidocaine 5% Patch 30s under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations worldwide. DMS Pharmaceutical Group Inc. is a...
- The Defense Logistics Agency issued a $2,192.76 delivery order to DMS Pharmaceutical Group Inc. on February 18, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for lidocaine 5% patch 30-count units. DMS Pharmaceutical Group Inc. is a woman-owned small business. The PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to Department of Defense healthcare facilities worldwide. Place of performance is Park...
- The Defense Logistics Agency awarded a $1,461.84 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30S. The award, issued on January 27, 2026, with an ultimate completion date of January 28, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,932.89 to DMS Pharmaceutical Group Inc. for Lidocaine 5% Patch 30s, with an ultimate completion date of October 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating its competitive capability in unrestricted federal procurement. The delivery order will be performed in...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Lidocaine 5% Patch 30s with a ceiling value of $5,062.40 under a firm fixed-price arrangement. This delivery order, awarded on November 27, 2025, with an ultimate completion date of November 28, 2025, was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to DMS Pharmaceutical Group Inc. on February 2, 2026, for lidocaine hydrochloride with a ceiling value of $2,343.00. The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency single-award indefinite delivery contract with a ceiling of $499.999 billion through December 31, 2036. PPV-G GEN V authorizes firm fixed-price delivery orders for...
- The Defense Logistics Agency awarded a delivery order valued at $1,055.88 to DMS Pharmaceutical Group Inc. for 30 units of Lidocaine 5% Patch on July 24, 2025. This firm fixed-price delivery order, which is set to be completed by July 25, 2025, will be performed at the contractor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to supply this topical anesthetic product to support federal healthcare needs. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,164.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Lidocaine 5% Patch 30s. The award, made on August 21, 2025, with an ultimate completion date of August 22, 2025, was issued under a firm fixed-price contract type with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,733.94 to DMS Pharmaceutical Group Inc. for the supply of Lidocaine 5% Patch 30s, with an ultimate completion date of September 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The place of performance is listed as Conshohocken, Pennsylvania. This delivery order...
- This is a $7,593.60 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for the supply of 4,563,767,512 units of Lidocaine 5% Patch 30s, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency...
- SPE2DR25D9331Indefinite Delivery Contract
- SPE2DR25D9331-SPE2DR26FQQH4Delivery Order
The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on February 20, 2026, for $21,927.60 to supply Lidocaine 5% Patch 30s, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract authorizing firm fixed-price delivery orders for pharmaceutical products and medical consumables to support Department of Defense healthcare operations globally. The parent IDC, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a $499.999 billion ceiling and extends through December 31, 2036. Place of performance is Park Ridge, IL 60068. The delivery order ultimate completion date is February 23, 2026. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler and sole awardee under the parent contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.9k | 2/19/26 |